Keyphrases
Mali
100%
Azithromycin
66%
Mass Drug Administration
66%
Clinical Trials
66%
Randomized Placebo-controlled Trial
66%
Cluster Randomized Trial
66%
Malawi
37%
Statistical Analysis Plan
33%
SARS-CoV-2 Antibodies
33%
SARS-CoV-2 Infection
33%
Lipid Supplementation
33%
Length-for-age
33%
Asymptomatic Infection
33%
Cesarean Section (C-section)
33%
Antibody Seroprevalence
33%
Linear Growth
33%
Randomized Controlled Trial
33%
Patient Health Care
33%
Cesarean Delivery
33%
Healthcare Workers
33%
Routine Surveillance
33%
Delivery Complications
27%
Health Centers
26%
Growth Factors
25%
Insulin-like
25%
Multiple Micronutrients
22%
Serosurvey
20%
Seroprevalence
20%
COVID-19
20%
Systemic Inflammation
16%
Shigella
16%
Collagen X
16%
Iron-folic Acid Supplementation
16%
Health Facilities
13%
Health Community
13%
Local Health
13%
Micronutrients
11%
Antimicrobial Resistance
10%
Seasonal Malaria Chemoprevention
10%
Direct Pathway
8%
Risk Factors
8%
Enterovirus
8%
Glycoprotein
8%
Enterovirus Infection
8%
Rhinovirus
8%
Inflammatory Biomarkers
8%
Intervention Targets
8%
Indirect Pathway
8%
Campylobacter Infections
8%
Norovirus Infection
8%
Immunology and Microbiology
Arm
66%
Antimicrobial Resistance
50%
Somatomedin C
33%
Population
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Seroprevalence
33%
Enterovirus
22%
Systemic Inflammation
22%
Campylobacter
22%
Insulin Blood Level
22%
Shigella
22%
Norovirus
22%
Cryptosporidium
22%
Parasitemia
16%
Nonoxynol-9
16%
Glycoprotein
11%
Infectious Agent
11%
Plasmodium
11%
Rhinovirus
11%
Orosomucoid
11%
Prevalence
11%
Blood Plasma
11%
Parechovirus
11%
Giardia intestinalis
11%
Rotavirus
11%
Medicine and Dentistry
Azithromycin
66%
Clinical Trial
66%
Placebo
66%
Drug Administration
66%
Arm
66%
Randomized Controlled Trial
33%
Cesarean Section
33%
Delivery Finding
33%
Trace Element
22%
Delivery Complication
18%
Folic Acid
11%
Iron
11%
Antibiotic Resistance
10%
Chemoprophylaxis
10%
Nutritional Status
7%
Cluster Randomized Trial
7%
